休息状态运动网络连接作为利沃多巴反应在帕金森病的生物标志物
Emma E Russo1,2, Leif E R Simmatis1,2, Kevin Kadak2
1Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Brain imaging and behavior
|February 11, 2026
概括
列沃多巴 (L-DOPA) 影响帕金森病 (PD) 患者的大脑连接. 了解这些变化可以帮助个性化L-DOPA治疗并减少副作用.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,影响全球数百万人.
- 利沃多巴 (L-DOPA) 是PD的主要治疗方法,但长期使用会导致运动并发症.
- 目前优化L-DOPA剂量的治疗工具有限.
研究的目的:
- 系统地审查关于L-DOPA对机动网络功能连接的影响的研究.
- 为开发精确和个性化的帕金森病治疗策略提供见解.
主要方法:
- 在PubMed和Web of Science的系统文献搜索.
- 包括研究L-DOPA诱导的人类休息状态功能连接的变化.
- 专注于与汽车网络相关的地区.
主要成果:
- L-DOPA广泛调节运动和认知静止状态网络中的连接.
- 观察到纹状体和皮层/皮下运动区域,小脑和脑干之间增加了连接性.
- 在一些比较中注意到脑内连接性下降,而小脑和中脑连接性普遍增加.
结论:
- 本综述描述了L-DOPA在帕金森病中调节运动网络连接的特征.
- 这些发现支持精确疗法和个性化L-DOPA剂量定位的进步.
- 洞察力可能有助于开发具有更好的副作用概况的治疗方法.
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Alterations in Muscle Tone lll
29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29


